You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.
The firm is part of a research consortium that is led by Mount Sinai and includes Fluidigm to develop a device to detect epigenetic signatures of WMD exposure.
Fluidigm will develop a microfluidic device for single-cell measurement of epigenetic changes under a broader $27.8 million DARPA-funded project.
The grant was awarded as part of DARPA's Epigenetic Characterization and Observation program, which aims to develop new approaches to epigenetic analysis.
The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.
With CRISPR being applied to a range of biological problems, researchers are searching for ways to stop its edits, Technology Review reports.
DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.
Scientists say that a DARPA project to use bugs to modify plant genes could be viewed as a bioweapon, the Associated Press reports.
The award expands an existing collaboration between the firms for automated organism design.
University of Washington researchers are collecting pictures from people to encode in DNA to explore its use as data storage device, Wired reports.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.